Global Protein and Peptide Therapeutics Market Growth (Status and Outlook) 2022-2028

Home/Global Protein and Peptide Therapeutics Market Growth (Status and Outlook) 2022-2028

Global Protein and Peptide Therapeutics Market Growth (Status and Outlook) 2022-2028

Pharma & Healthcare, Drug Delivery, Treatments, Pharmaceutical Manufacturing

Publication ID:

ARS0821044

Publication Date:

August 04, 2021

Pages:

125

Publisher:

Arsta

Region:

Global

$3,660.00

Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.

Printer version

Send by email

PDF version

Tabs

Description

As the global economy recovers in 2021 and the supply of the industrial chain improves, the Protein and Peptide Therapeutics market will undergo major changes. According to the latest research, the market size of the Protein and Peptide Therapeutics industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.

The global Protein and Peptide Therapeutics industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Protein and Peptide Therapeutics market during the next few years. The global Protein and Peptide Therapeutics market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

This report presents a comprehensive overview, market shares, and growth opportunities of Protein and Peptide Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Injection
Oral

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Cancer
Metabolic Disorders
Central Nervous System
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J

Table of Contents

Table of Content

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Protein and Peptide Therapeutics Market Size 2017-2028
2.1.2 Protein and Peptide Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Protein and Peptide Therapeutics Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Protein and Peptide Therapeutics Market Size by Type
2.3.1 Protein and Peptide Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Protein and Peptide Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Protein and Peptide Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Protein and Peptide Therapeutics Market Size by Application
2.5.1 Protein and Peptide Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Protein and Peptide Therapeutics Market Size Market Share by Application (2017-2022)

3 Protein and Peptide Therapeutics Market Size by Player
3.1 Protein and Peptide Therapeutics Market Size Market Share by Players
3.1.1 Global Protein and Peptide Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Protein and Peptide Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Protein and Peptide Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Protein and Peptide Therapeutics by Regions
4.1 Protein and Peptide Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Protein and Peptide Therapeutics Market Size Growth (2017-2022)
4.3 APAC Protein and Peptide Therapeutics Market Size Growth (2017-2022)
4.4 Europe Protein and Peptide Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Protein and Peptide Therapeutics Market Size Growth (2017-2022)

5 Americas
5.1 Americas Protein and Peptide Therapeutics Market Size by Country (2017-2022)
5.2 Americas Protein and Peptide Therapeutics Market Size by Type (2017-2022)
5.3 Americas Protein and Peptide Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Protein and Peptide Therapeutics Market Size by Region (2017-2022)
6.2 APAC Protein and Peptide Therapeutics Market Size by Type (2017-2022)
6.3 APAC Protein and Peptide Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Protein and Peptide Therapeutics by Country (2017-2022)
7.2 Europe Protein and Peptide Therapeutics Market Size by Type (2017-2022)
7.3 Europe Protein and Peptide Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Protein and Peptide Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Protein and Peptide Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Protein and Peptide Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 Global Protein and Peptide Therapeutics Market Forecast
10.1 Global Protein and Peptide Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Protein and Peptide Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Protein and Peptide Therapeutics Forecast
10.1.3 APAC Protein and Peptide Therapeutics Forecast
10.1.4 Europe Protein and Peptide Therapeutics Forecast
10.1.5 Middle East & Africa Protein and Peptide Therapeutics Forecast
10.2 Americas Protein and Peptide Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Protein and Peptide Therapeutics Market Forecast
10.2.2 Canada Protein and Peptide Therapeutics Market Forecast
10.2.3 Mexico Protein and Peptide Therapeutics Market Forecast
10.2.4 Brazil Protein and Peptide Therapeutics Market Forecast
10.3 APAC Protein and Peptide Therapeutics Forecast by Region (2023-2028)
10.3.1 China Protein and Peptide Therapeutics Market Forecast
10.3.2 Japan Protein and Peptide Therapeutics Market Forecast
10.3.3 Korea Protein and Peptide Therapeutics Market Forecast
10.3.4 Southeast Asia Protein and Peptide Therapeutics Market Forecast
10.3.5 India Protein and Peptide Therapeutics Market Forecast
10.3.6 Australia Protein and Peptide Therapeutics Market Forecast
10.4 Europe Protein and Peptide Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Protein and Peptide Therapeutics Market Forecast
10.4.2 France Protein and Peptide Therapeutics Market Forecast
10.4.3 UK Protein and Peptide Therapeutics Market Forecast
10.4.4 Italy Protein and Peptide Therapeutics Market Forecast
10.4.5 Russia Protein and Peptide Therapeutics Market Forecast
10.5 Middle East & Africa Protein and Peptide Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Protein and Peptide Therapeutics Market Forecast
10.5.2 South Africa Protein and Peptide Therapeutics Market Forecast
10.5.3 Israel Protein and Peptide Therapeutics Market Forecast
10.5.4 Turkey Protein and Peptide Therapeutics Market Forecast
10.5.5 GCC Countries Protein and Peptide Therapeutics Market Forecast
10.6 Global Protein and Peptide Therapeutics Forecast by Type (2023-2028)
10.7 Global Protein and Peptide Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Protein and Peptide Therapeutics Product Offered
11.1.3 Sanofi Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Protein and Peptide Therapeutics Product Offered
11.2.3 Teva Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Protein and Peptide Therapeutics Product Offered
11.3.3 Novo Nordisk Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Protein and Peptide Therapeutics Product Offered
11.4.3 Takeda Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Protein and Peptide Therapeutics Product Offered
11.5.3 Eli Lilly Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Protein and Peptide Therapeutics Product Offered
11.6.3 AstraZeneca Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Protein and Peptide Therapeutics Product Offered
11.7.3 Novartis Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Protein and Peptide Therapeutics Product Offered
11.8.3 AbbVie Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Protein and Peptide Therapeutics Product Offered
11.9.3 Ipsen Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Protein and Peptide Therapeutics Product Offered
11.10.3 Ferring Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Protein and Peptide Therapeutics Product Offered
11.11.3 Merck Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Protein and Peptide Therapeutics Product Offered
11.12.3 The Medicines Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Protein and Peptide Therapeutics Product Offered
11.13.3 J & J Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments

12 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Protein and Peptide Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Injection
Table 3. Major Players of Oral
Table 4. Protein and Peptide Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Protein and Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Protein and Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 7. Protein and Peptide Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Protein and Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Protein and Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 10. Global Protein and Peptide Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Protein and Peptide Therapeutics Revenue Market Share by Player (2020-2022)
Table 12. Protein and Peptide Therapeutics Key Players Head office and Products Offered
Table 13. Protein and Peptide Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Protein and Peptide Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Protein and Peptide Therapeutics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Protein and Peptide Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Protein and Peptide Therapeutics Market Size Market Share by Country (2017-2022)
Table 20. Americas Protein and Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Protein and Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 22. Americas Protein and Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Protein and Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 24. APAC Protein and Peptide Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Protein and Peptide Therapeutics Market Size Market Share by Region (2017-2022)
Table 26. APAC Protein and Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Protein and Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 28. APAC Protein and Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Protein and Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 30. Europe Protein and Peptide Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Protein and Peptide Therapeutics Market Size Market Share by Country (2017-2022)
Table 32. Europe Protein and Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Protein and Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 34. Europe Protein and Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Protein and Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Protein and Peptide Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Protein and Peptide Therapeutics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Protein and Peptide Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Protein and Peptide Therapeutics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Protein and Peptide Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Protein and Peptide Therapeutics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Protein and Peptide Therapeutics
Table 43. Key Market Challenges & Risks of Protein and Peptide Therapeutics
Table 44. Key Industry Trends of Protein and Peptide Therapeutics
Table 45. Global Protein and Peptide Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Protein and Peptide Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Protein and Peptide Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Protein and Peptide Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Protein and Peptide Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Protein and Peptide Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Sanofi Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 52. Sanofi Protein and Peptide Therapeutics Product Offered
Table 53. Sanofi Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. Teva Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 57. Teva Protein and Peptide Therapeutics Product Offered
Table 58. Teva Main Business
Table 59. Teva Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Teva Latest Developments
Table 61. Novo Nordisk Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 62. Novo Nordisk Protein and Peptide Therapeutics Product Offered
Table 63. Novo Nordisk Main Business
Table 64. Novo Nordisk Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Novo Nordisk Latest Developments
Table 66. Takeda Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 67. Takeda Protein and Peptide Therapeutics Product Offered
Table 68. Takeda Main Business
Table 69. Takeda Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Takeda Latest Developments
Table 71. Eli Lilly Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 72. Eli Lilly Protein and Peptide Therapeutics Product Offered
Table 73. Eli Lilly Main Business
Table 74. Eli Lilly Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Eli Lilly Latest Developments
Table 76. AstraZeneca Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 77. AstraZeneca Protein and Peptide Therapeutics Product Offered
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. AstraZeneca Latest Developments
Table 81. Novartis Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 82. Novartis Protein and Peptide Therapeutics Product Offered
Table 83. Novartis Main Business
Table 84. Novartis Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Novartis Latest Developments
Table 86. AbbVie Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 87. AbbVie Protein and Peptide Therapeutics Product Offered
Table 88. AbbVie Main Business
Table 89. AbbVie Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. AbbVie Latest Developments
Table 91. Ipsen Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 92. Ipsen Protein and Peptide Therapeutics Product Offered
Table 93. Ipsen Main Business
Table 94. Ipsen Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Ipsen Latest Developments
Table 96. Ferring Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 97. Ferring Protein and Peptide Therapeutics Product Offered
Table 98. Ferring Main Business
Table 99. Ferring Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Ferring Latest Developments
Table 101. Merck Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 102. Merck Protein and Peptide Therapeutics Product Offered
Table 103. Merck Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Merck Main Business
Table 105. Merck Latest Developments
Table 106. The Medicines Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 107. The Medicines Protein and Peptide Therapeutics Product Offered
Table 108. The Medicines Main Business
Table 109. The Medicines Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. The Medicines Latest Developments
Table 111. J & J Details, Company Type, Protein and Peptide Therapeutics Area Served and Its Competitors
Table 112. J & J Protein and Peptide Therapeutics Product Offered
Table 113. J & J Main Business
Table 114. J & J Protein and Peptide Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. J & J Latest Developments
List of Figures
Figure 1. Protein and Peptide Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Protein and Peptide Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Protein and Peptide Therapeutics Market Size Market Share by Type in 2021
Figure 7. Protein and Peptide Therapeutics in Cancer
Figure 8. Global Protein and Peptide Therapeutics Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Protein and Peptide Therapeutics in Metabolic Disorders
Figure 10. Global Protein and Peptide Therapeutics Market: Metabolic Disorders (2017-2022) & ($ Millions)
Figure 11. Protein and Peptide Therapeutics in Central Nervous System
Figure 12. Global Protein and Peptide Therapeutics Market: Central Nervous System (2017-2022) & ($ Millions)
Figure 13. Protein and Peptide Therapeutics in Other
Figure 14. Global Protein and Peptide Therapeutics Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Protein and Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 16. Global Protein and Peptide Therapeutics Revenue Market Share by Player in 2021
Figure 17. Global Protein and Peptide Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Protein and Peptide Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. APAC Protein and Peptide Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Europe Protein and Peptide Therapeutics Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Protein and Peptide Therapeutics Market Size 2017-2022 ($ Millions)
Figure 22. Americas Protein and Peptide Therapeutics Value Market Share by Country in 2021
Figure 23. Americas Protein and Peptide Therapeutics Consumption Market Share by Type in 2021
Figure 24. Americas Protein and Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 25. United States Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Protein and Peptide Therapeutics Market Size Market Share by Region in 2021
Figure 30. APAC Protein and Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 31. China Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Protein and Peptide Therapeutics Market Size Market Share by Country in 2021
Figure 38. Europe Protein and Peptide Therapeutics Market Size Market Share by Type in 2021
Figure 39. Europe Protein and Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 40. Germany Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Protein and Peptide Therapeutics Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Protein and Peptide Therapeutics Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Protein and Peptide Therapeutics Market Size Market Share by Application in 2021
Figure 48. Egypt Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Protein and Peptide Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. APAC Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Europe Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. United States Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Canada Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. China Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Japan Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Korea Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. India Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Australia Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Germany Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. France Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. UK Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Italy Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Russia Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Spain Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Israel Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Protein and Peptide Therapeutics Market Size 2023-2028 ($ Millions)

Companies Covered

Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Report Enquiry

Do you need more information about this report before making a purchase decision or wish to customize this report to suite your requirements?

If yes, then please use the form given below and we will get in touch with you immediately.

Kindly use your official email address and contact number to ensure speedy response.

Name *

Email *

Company

Contact Number *

Report Title *

Your Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Drag or click the correct shape to the grey "drop area".